Cover Image

Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction

Saved in:

Bibliographic Details
Main Authors:	Satoshi Nakamizo (Author), Yoshiki Miyachi (Author), Kenji Kabashima (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis
by: Zhanhan TANG, et al.
Published: (2023)

Meta-analysis of efficacy and safety of adalimumab injection for arthropathic psoriasis
by: Nan LI, et al.
Published: (2019)

Visual Loss Induced by Adalimumab Used for Plaque Psoriasis
by: Norman Saffra, et al.
Published: (2017)

Depression Over Psoriasis: Assessment of associated Relief by addition of ADalimumab for the treatment of Psoriasis: Observational study (DORADO - Ps)
by: Ayman Elgendi, et al.
Published: (2015)

Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis
by: Esra Yıldırım Bay, et al.
Published: (2021)

Adalimumab for severe psoriasis in Chilean paediatric patients,
by: Daniela Armijo Fernandez, et al.
Published: (2020)

Unilateral Verrucous Psoriasis Successfully Treated With Adalimumab
by: Artur Antônio Duarte, et al.
Published: (2024)

Adalimumab
by: Nilgun Atakan
Published: (2022)

Adalimumab-induced lupus pernio-like eruption in a patient with psoriasis
by: Po-Hua Chen
Published: (2015)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
by: Nicolazzo D, et al.
Published: (2014)

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
by: Savas Yayli, et al.
Published: (2013)

Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
by: Changkun Li, et al.
Published: (2023)

Palmoplantar Psoriasis Resistant to Adalimumab Successfully Treated With Bimekizumab
by: Emanuele Trovato, et al.
Published: (2024)

Acneiform eruptions and inflammatory striae as probable reactions to adalimumab
by: Shilpa Garg, et al.
Published: (2018)

Adalimumab induced psoriasis during the treatment of inflammatory bowel disease - case report
by: Edyta Lelonek, et al.
Published: (2015)

Adalimumab-Induced Erythrodermic Psoriasis Associated with Alopecia in a Patient with Palmoplantar Pustulosis
by: Ying Wang, et al.
Published: (2024)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
by: Yijia Jiang, et al.
Published: (2023)

Disfiguring Annular Sarcoidosis Improved by Adalimumab
by: C.A. Kaiser, et al.
Published: (2011)

Improvement of Anti-TNF-α Antibody-Induced Palmoplantar Pustular Psoriasis Using a 308-nm Excimer Light
by: Natsuko Iga, et al.
Published: (2012)

Development of lichen striatus in a psoriasis patient treated with adalimumab
by: I-Chun Lin, et al.
Published: (2015)

Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
by: Natallia Barreiros de Natividade, et al.
Published: (2017)

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
by: Zhou X, et al.
Published: (2021)

Silicone-induced granulomas successfully treated with adalimumab
by: Francisco Javier de la Torre Gomar, et al.
Published: (2023)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
by: Aline Lissa Okita, et al.
Published: (2020)

The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
by: M. Panahi, et al.
Published: (2021)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
by: Timothy Fitzgerald, et al.
Published: (2023)

Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy
by: Georgios Kokolakis, et al.
Published: (2020)

Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment
by: Soichiro Ikeya, et al.
Published: (2021)

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab
by: Lei Wang, et al.
Published: (2021)

Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
by: Xiaoliang Ding, et al.
Published: (2020)

Treatment of granulomatous rosacea with adalimumab
by: Ryan C. Saal, BS, et al.
Published: (2023)

Severe plaque psoriasis with coexisting cicatricial alopecia treated with adalimumab - case report
by: Dorota Krasowska, et al.
Published: (2014)

Lithium-Associated Generalized Ostraceous Psoriasis Treated with Adalimumab: A Case Report
by: Yang Y, et al.
Published: (2023)

Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
by: Annunziata Raimondo, MD, et al.
Published: (2021)

Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab
by: Mirjam Fässler, MD, et al.
Published: (2020)

Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa
by: Carlo Alberto Vignoli, et al.
Published: (2023)

Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
by: Pei-Han Kao, et al.
Published: (2015)

Uveitis occurring in a patient with psoriasis during adalimumab therapy: A case report
by: Qiaoli Zheng, et al.
Published: (2022)

Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis
by: Dandan HU, et al.
Published: (2023)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
by: Chu Y, et al.
Published: (2022)